超越肌节解释肥厚型心肌病异质性:JACC综述
该综述指出,仅用单肌节基因突变无法充分解释肥厚型心肌病(HCM)的所有临床和病理特征,约70%确诊患者无致病肌节突变,且携带者可不发病。作者建议采用网络医学等新分析方法,拓展研究焦点以解释HCM的整体复杂性。
要点
- 约70%确诊HCM患者无致病肌节突变,单肌节假说解释力有限。
- 肌节基因携带者可终身不发病,提示存在其他修饰因素。
- HCM的部分特征涉及不表达心肌肌节蛋白的组织类型。
核心结论
- 单肌节基因突变不足以解释HCM的全部临床和病理生物学特征,需拓展研究模型。
研究设计与样本
- 综述类文章,检索范围未在摘要中报告。
主要发现
- 约70%确诊HCM患者不存在致病肌节突变。
- 肌节基因携带者可存活至高龄而不发生HCM。
- HCM的局部左心室肥厚、心肌纤维化、二尖瓣叶延长及壁内冠状动脉小动脉重构等特征涉及不表达心肌肌节蛋白的组织类型。
关键数值与推荐
- 约70%确诊HCM患者无致病肌节突变。
临床怎么用
- 临床认识HCM异质性时应超越单肌节基因模型,关注其他病理机制。
- 可关注网络医学等新分析方法在HCM研究中的应用前景。
局限性
- 摘要未报告综述的检索范围及纳入文献特征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hypertrophic cardiomyopathy (HCM) has been considered a heterogeneous cardiac disease ascribed solely to single sarcomere gene mutations. However, limitations of this hypothesis suggest that sarcomere mutations alone do not adequately explain all HCM clinical and pathobiological features. Disease-causing sarcomere mutations are absent in ∼70% of patients with established disease, and sarcomere gene carriers can live to advanced ages without developing HCM. Some features of HCM are also inconsistent with the single sarcomere gene hypothesis, such as regional left ventricular hypertrophy and myocardial fibrosis, as well as structurally abnormal elongated mitral valve leaflets and remodeled intramural coronary arterioles, which involve tissue types that do not express cardiomyocyte sarcomere proteins. It is timely to expand the HCM research focus beyond a single molecular event toward more inclusive models to explain this disease in its entirety. The authors chart paths forward addressing this knowledge gap using novel analytical approaches, particularly network medicine, to unravel the pathobiological complexity of HCM.
引用
- Maron BJ, Maron MS, Maron BA, et al. Moving Beyond the Sarcomere to Explain Heterogeneity in Hypertrophic Cardiomyopathy: JACC Review Topic of the Week. J Am Coll Cardiol. 2019. PMID: 31000001. doi:10.1016/j.jacc.2019.01.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。